Literature DB >> 16681142

Antimicrobial activity of ZnII, CdII, and HgII complexes of 1,2-bis-[2-(5-R)-1H-benzimidazolyl]-1,2-ethanediols and 1,4-bis-[2-(5-R)-1H-benzimidazolyl]-1,2,3,4-butanetetraols.

A Tavman1, S Birteksöz, G Otük.   

Abstract

1,2-Bis-[2-(5-H/Me/Cl/NO2)-1H-benzimidazolyl]-1,2-ethanediols (L1-L4), 1,4-bis-[2-(5-H/Me/Cl)-1H-benzimidazolyl]-1,2,3,4-butanetetraols (L5-L7) and their complexes with ZnCl2, CdCl2 and HgCl2 were synthesized and antibacterial activity of the compounds was tested toward Staphylococcus aureus, S. epidermidis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella typhi, Shigella flexneri, Proteus mirabilis and antifungal activity against Candida albicans. HgII complexes have a considerably higher antimicrobial activity against all microorganisms. Some HgII complexes show higher antifungal activity than clotrimazole toward C. albicans. Zn2(L3)Cl4, Zn2(L4)Cl4, and Cd(L3)Cl2 were moderately effective against S. aureus and S. epidermidis; Cd(L4)Cl2 exhibited a weak activity only against S. epidermidis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16681142     DOI: 10.1007/BF02931432

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.629


  10 in total

1.  Antifungal activity of some bis-5-methylbenzimidazole compounds.

Authors:  H Küçükbay; R Durmaz; N Okyucu; S Günal
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Antifungal activity of organic and organometallic derivatives of benzimidazole and benzothiazole.

Authors:  H Küçükbay; B Durmaz
Journal:  Arzneimittelforschung       Date:  1997-05

3.  Synthesis and preliminary evaluation of benzimidazole derivatives as antimicrobial agents.

Authors:  Vera Klimesová; Jan Kocí; Milan Pour; Jirí Stachel; Karel Waisser; Jarmila Kaustová
Journal:  Eur J Med Chem       Date:  2002-05       Impact factor: 6.514

4.  New benzimidazole derivatives as antimycobacterial agents.

Authors:  Vera Klimesová; Jan Kocí; Karel Waisser; Jarmila Kaustová
Journal:  Farmaco       Date:  2002-04

5.  Synthesis and antitumour activity of trimethylsilylpropyl substituted benzimidazoles.

Authors:  E Lukevics; P Arsenyan; I Shestakova; I Domracheva; A Nesterova; O Pudova
Journal:  Eur J Med Chem       Date:  2001-06       Impact factor: 6.514

6.  Copper complexes with bioactive ligands Part I--Antimicrobial activity.

Authors:  B Dudová; D Hudecová; R Pokorný; M Mikulásová; M Palicová; P Segl'a; M Melník
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

7.  Copper complexes with bioactive ligands. Part II--Antifungal activity.

Authors:  B Dudová; D Hudecová; R Pokorný; M Micková; M Palicová; P Segĺa; M Melník
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

8.  Antimicrobial activity of FeIII, CuII, AgI, ZnII and HgII complexes of 2-(2-hydroxy-5-bromo/nitro-phenyl)-1H- and 2-(2-hydroxyphenyl)-5-methyl/chloro/nitro-1H-benzimidazoles.

Authors:  B Ulküseven; A Tavman; G Otük; S Birteksöz
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

9.  Antimicrobial activity of 1,2-bis-[2-(5-R)-1H-benzimidazolyl]- 1,2-ethanediols, 1,4-bis-[2-(5-R)-1H-benzimidazolyl]- 1,2,3,4-butanetetraols and their FeIII, CuII, and AgI complexes.

Authors:  A Tavman; S Birteksöz; G Otük
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.629

10.  Antimicrobial activity of some 2- and 3-pyridinyl-1H-benzimidazoles and their FeIII, CuII, ZnII, and AgI complexes.

Authors:  A Tavman; B Ulküseven; S Birteksöz; G Otük
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.